UCL Therapeutic Innovation Networks


Funding Opportunities

New funding schemes for early career researchers are available for each of the TINs, to support the generation of pilot data for translational research projects.

The TINs Pilot Data Scheme is highlighted by the TRO in the below video, and also features previous awardees from previous calls who describe how the scheme enabled them to learn crucial skills, generate data & lead to follow-on funding.

MediaCentral Widget Placeholderhttps://mediacentral.ucl.ac.uk/Player/013h1hf8

Case studies of previous awardees:

For all opportunities, shortlisted applicants will be required to deliver a 2-minute pitch of their proposal followed by 10mins Q&A to a panel of academic and industrial members at a Dragon’s Den style event.

  • Who can apply: Postdoctoral Researchers (PDRA) and non-tenured Principal Investigators. 
  • Who cannot apply: PhD students, Research technicians, tenured Principal Investigators, etc. 
  • Download application form: https://bit.ly/3AVnNcD
  • Training information: https://bit.ly/3UaVf5S
  • Funding application deadline: Friday 20th January 2023, 1pm
Closed - TIN Pilot Data Scheme - Call 3 (2023) 

The TINs committees are now inviting applications for projects with an aim to accelerate the transition from discovery science to the early stages of therapeutic development by providing responsive and flexible funding to support preliminary translational work. 

What we are looking for: 

  • Cell and Gene Therapy TIN: Translational projects involving viral and non-viral gene delivery, direct and ex-vivo gene therapy, gene supplementation, gene editing, TCR and CAR-T cells. 
  • Regenerative Medicine TIN: Translational projects involving cells, engineered tissues and biomaterials for therapeutic applications. 
  • Small Molecules TIN: Translational drug discovery projects involving the development, optimisation or testing of new small molecules. 
  • Devices, Diagnostics and Digital TIN: Translational projects involving the development of therapeutic devices, diagnostic devices, screening tests, prognostic biomarkers.
  • Biologics TIN: Translational projects involving the development of monoclonal antibodies, peptides, vaccines, exosomes and oligonucleotides therapies.
  • Medicines Repurposing TIN: Translational projects involving the use of marketed drugs for novel medical indications. Screening projects aiming at the identification of new potential molecules without a clear and focused repurposing activity are excluded from this call.

Level of funding: £5-10k 

Duration of funding: 6 months

Application deadline: Friday 20th January 2023, 1pm. 

For more information about the scheme and to apply, please download and complete the application form (which also includes details of associated training opportunities) and return it the deadline Friday 20th January 2023, 1pm. Please forward any questions to TIN Coordinator Dr Asha Recino in the first instance.